March 18, 2025 - 15:51

Israeli startup REE Automotive has announced its expectations to generate revenue of up to $770 million by the year 2030 through a licensing agreement with an undisclosed company. This deal focuses on providing advanced technology for the development of autonomous vehicles.
REE, which has established partnerships with notable clients such as van rental company U-Haul and French aerospace giant Airbus, revealed that it has already signed a preliminary agreement with the unnamed firm and is on track to finalize a definitive contract shortly.
The innovative company has strategically avoided the significant manufacturing investments that have burdened many electric vehicle startups. Instead, REE is focusing on leveraging its proprietary technology through licensing, positioning itself as a key player in the evolving automotive landscape. This approach not only minimizes financial risk but also allows REE to scale its operations effectively while contributing to the advancement of autonomous vehicle technology.
March 2, 2026 - 07:46
Canon: "New Technology" Compact Model is ComingPhotography enthusiasts and industry watchers are abuzz as Canon has released tantalizing hints about a new compact camera model currently in development. While full specifications and an official...
March 1, 2026 - 18:53
Digital Frontiers Reshape Montana's LandscapeThe spirit of innovation that once rode the rails into Montana is finding new expression in the digital age. Across the state, from sprawling ranches to remote mountain towns, modern technology is...
March 1, 2026 - 04:37
Silicon Valley Rallies Behind Anthropic in A.I. Clash With TrumpA significant rift appears to be widening between the federal government and the American technology sector, as industry leaders and workers rally behind artificial intelligence startup Anthropic....
February 28, 2026 - 04:58
Rare Disease Day: Revolutionising clinical trial enrolment and retention with technologyOn Rare Disease Day, the focus sharpens on the unique challenges of developing treatments for conditions affecting small, often geographically dispersed patient populations. A key industry expert...